Ms Brudon has extensive experience as a researcher, a policy maker and campaigner in health, medicines and pharmaceuticals. She has been successful in supporting development and implementation of pharmaceutical policies in countries all over the world; in designing operational research and monitoring and evaluating tools in the area of pharmaceuticals and health policies; in facilitating dialogue and joint policy-making with various stakeholders in several national and international initiatives.
Pharmacist, with postgraduate specialization in public health and development, she began her carrier in WHO in 1984 in the newly created Action Programme on Essential Drugs (DAP). She supported countries, mainly in Africa and Asia in developing and implementing national medicines policies based on the essential drug concept, including the development of innovative approaches for improving availability, affordability and use of medicines. She developed and coordinated operational research (OR), and created an OR series in DAP. She participated actively in major events in the area of medicines, including in the Nairobi conference in 1986 on Rational Use of Drugs and was the main author of key documents, such as the first World Drug Situation published in 1988.
In 1997, she became chief of the Programme Evaluation in the Division of Policy, Programme and Evaluation of WHO, and contributed to the design of tools and manuals for evaluating WHO programmes. She was nominated WHO Representative for Vietnam in 1999: During the 5 years of her term, she worked closely with the government and other partners on public health issues, including medicines, HIV-Aids, non communicable diseases, tobacco, SARS and avian flu. On her return to Geneva, she was in charge of developing in collaboration with all the departments of WHO and the Regional offices a global health agenda: the 11th General Programme of Work of WHO for the period 2006-2015, “Engaging for Health”.
From 2006 to the present, she has been working as a consultant on issues related to pharmaceuticals, social determinants and health, etc. and has been involved with NGOs, mainly Health Action International (HAI), a global network of over 200 members, including consumer groups, public interest NGOs, health care providers, academics, media and grassroots people in more than 70 countries.
Ms Brudon has authored and co-authored over 30 publications on pharmaceuticals issues.